Prenetics Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program
LOS ANGELES, June 17, 2024 (GLOBE NEWSWIRE) — Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven […]
GigaCloud Technology Inc’s Founder, Chairman, and CEO Larry Wu Named Entrepreneur Of The Year® 2024 Greater Los Angeles Award Winner
EL MONTE, Calif., June 17, 2024 (GLOBE NEWSWIRE) — GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer […]
Chijet Motor Company, Inc.’s Subsidiary Signed Cooperation Agreement with the Auto Dealer of Algeria
JILIN CITY, China, June 17, 2024 (GLOBE NEWSWIRE) — Chijet Motor Company, Inc. (Nasdaq: CJET) (the “Company” or “Chijet”), a […]
Microbot Medical Announces Brigham and Women’s Hospital as a Site for its Pivotal Human Clinical Trial
BRAINTREE, Mass., June 17, 2024 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT) today announces that Brigham and Women’s Hospital […]
Atossa Set to Join Russell 3000® Index Effective June 28, 2024
SEATTLE, June 17, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced its expected […]
Jon Wilk Named Visionary CEO at Banking Tech Awards
SOMERSET, N.J., June 17, 2024 (GLOBE NEWSWIRE) — CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and […]
Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
– Initiative aimed at improving access and outcomes for patients with recurrent pericarditis – – American Heart Association to work with […]
Sharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in Colombia
NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) — Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and […]
Goodness Growth Holdings Announces Closing of Recently Announced Non-Brokered Private Placement
MINNEAPOLIS, June 17, 2024 (GLOBE NEWSWIRE) — Goodness Growth Holdings, Inc. (“Goodness Growth” or the “Company”) (CSE: GDNS; OTCQX: GDNSF), a […]
Aprea Therapeutics Announces First Patient Dosed in ACESOT-1051 Phase 1 Trial Evaluating Oral WEE1 Inhibitor APR-1051
APR-1051 is a highly selective and potentially best-in-class oral WEE1 inhibitor Phase 1 ACESOT-1051 clinical trial is evaluating APR-1051 as monotherapy […]
